Italy to receive 40,000 Merck antiviral drug doses next week

Italy will receive around 40,000 doses of Merck & Co’s (MRK.N) COVID-19 antiviral drug next week, which will add to nearly 12,000 already distributed to hospitals, the special COVID-19 commissioner said on Sunday.

“They are intended for clinical cases that risk a serious outcome of the disease,” Commissioner Francesco Figliuolo told a television program on Italy’s RAI 3 channel.

JPMorgan Multi-Asset Growth & Income plc (LON:MATE) combines sustainable income and capital growth from globally diversified investments. The Trust aims to achieve a long-term total return of 6% per annum and an initial annual dividend of 4% paid quarterly.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

More articles like this

JPMorgan Multi-Asset Growth & Income plc MATE investor presentation

Portfolio Manager Gareth Witcomb of JPMorgan Multi-Asset Growth & Income Trust PLC (LON:MATE) presents a recent AGM meeting on 6 July 2021. JPMorgan Multi-Asset Growth & Income plc combines sustainable income and capital growth from globally diversified investments.

Multi-asset income fund MATE rises on continued positive returns

JPMorgan Multi-Asset Growth & Income plc (LON:MATE) published their ‘month in review’ for July 2021.  Tim Mitchell, Investment Trust Client Director, at J.P. Morgan Asset Management, commented on the positive July performance of the trust and the economic outlook as